CIK 0001773751
- Large accelerated filer
Hims & Hers Health, Inc.
Sign in to watch- Ticker
- HIMS
- Exchange
- NYSE
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 415-851-0195
- Business address
- 2269 CHESTNUT ST, #523, SAN FRANCISCO, CA, 94123
- Former names
- Oaktree Acquisition Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,483,933
- in 10 filings, $2.5M under 10b5-1 plans
Net −$2,483,933. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-10-16 | Dudum Andrew Chief Executive Officer | Sale 10b5-1 | −39,531 | $62.71 | $2.5M | 161,326 |
| 2025-10-16 | Dudum Andrew Chief Executive Officer | Sale 10b5-1 | −10,469 | $63.49 | $665K | 150,857 |
| 2025-10-16 | Dudum Andrew Chief Executive Officer | Sale 10b5-1 | −39,332 | $62.70 | $2.5M | 111,525 |
| 2025-10-16 | Dudum Andrew Chief Executive Officer | Sale 10b5-1 | −2,335 | $63.39 | $148K | 109,190 |
| 2025-10-16 | Dudum Andrew Chief Executive Officer | Sale 10b5-1 | −16,667 | $62.70 | $1.0M | 92,523 |
| 2025-10-16 | Dudum Andrew Chief Executive Officer | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −17,001 | 17,005 | ||
| 2025-10-16 | Dudum Andrew Chief Executive Officer | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −108,334 | 431,395 | ||
| 2025-10-13 | Boughton Soleil Chief Legal Officer | Sale 10b5-1 | −2,637 | $54.38 | $143K | 161,130 |
| 2025-10-10 | Chi Michael Chief Commercial Officer | Exercise or conversion 10b5-1 | +900 | $6.82 | $6K | 292,339 |
| 2025-10-10 | Chi Michael Chief Commercial Officer | Sale 10b5-1 | −900 | $58.25 | $52K | 291,439 |
| 2025-10-10 | Chi Michael Chief Commercial Officer | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −900 | 115,362 | ||
| 2025-10-03 | Okupe Oluyemi Chief Financial Officer | Exercise or conversion 10b5-1 | +7,787 | $5.01 | $39K | 78,019 |
| 2025-10-03 | Okupe Oluyemi Chief Financial Officer | Exercise or conversion 10b5-1 | +3,808 | $11.53 | $44K | 81,827 |
| 2025-10-03 | Okupe Oluyemi Chief Financial Officer | Sale 10b5-1 | −11,595 | $57.72 | $669K | 70,232 |
| 2025-10-03 | Okupe Oluyemi Chief Financial Officer | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −7,787 | 182,165 | ||
| 2025-10-03 | Okupe Oluyemi Chief Financial Officer | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −3,808 | 59,976 | ||
| 2025-10-01 | Chi Michael Chief Commercial Officer | Exercise or conversion 10b5-1 | +250 | $11.53 | $3K | 291,689 |
| 2025-10-01 | Chi Michael Chief Commercial Officer | Sale 10b5-1 | −250 | $56.00 | $14K | 291,439 |
| 2025-10-01 | Chi Michael Chief Commercial Officer | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −250 | 47,106 | ||
| 2025-09-29 | Okupe Oluyemi Chief Financial Officer | Exercise or conversion 10b5-1 | +49,832 | $5.01 | $250K | 155,232 |
Page 21 of 37 · 739 trades